Silver

Silver

SCHEMBL1780940

[Ag+].[C].[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Silver SCHEMBL7982932 0.87
Silver SCHEMBL931222 0.82
Silver SCHEMBL7456089 0.82
Silver SCHEMBL20526 0.82
Silver SCHEMBL10628328 0.82
Silver SCHEMBL2566285 0.67
Silver SCHEMBL9676231 0.67
Ammonia Solution, Strong SCHEMBL1830438 0.67
Charcoal, Activated SCHEMBL9750637 0.67
Silver SCHEMBL501913 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2498867-B1 GALVANIC SKIN TREATMENT DEVICE JOHNSON & JOHNSON CONSUMER INC (US) 2016-12-21 EP disclosed
CN-105289664-A Efficient and stable silver chloride photocatalyst preparation method UNIV HUBEI ARTS & SCIENCE 2016-02-03 CN disclosed
CN-102711905-B Galvanic skin treatment device JOHNSON & JOHNSON CONSUMER 2015-06-17 CN disclosed
US-9050452-B2 Device for treatment of a barrier membrane JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2015-06-09 US disclosed
CN-104147694-A Device for treating human or animal barrier film JOHNSON & JOHNSON CONSUMER 2014-11-19 CN disclosed
US-8784460-B2 Microcurrent device with a sensory cue MCNEIL-PPC, INC. (US) 2014-07-22 US disclosed
US-8744567-B2 Galvanic skin treatment device JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2014-06-03 US disclosed
US-8734421-B2 Methods of treating pores on the skin with electricity JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2014-05-27 US disclosed
CN-101878053-B Microcurrent device with sensory cue MCNEIL PPC INC 2014-04-09 CN disclosed
EP-1644076-B1 Topical composition for treating acne and rosacea with galvanic generated electricity JOHNSON & JOHNSON CONSUMER (US) 2013-12-25 EP disclosed
US-20050010192-A1 Methods of treating pores on the skin with electricity JOHNSON & JOHNSON CONSUMER INC. 2005-01-13 US disclosed
US-20050010161-A1 Methods of treating acne and rosacea with galvanic generated electricity JOHNSON & JOHNSON CONSUMER INC. 2005-01-13 US disclosed
US-20050004550-A1 Methods of treating a wound with galvanic generated electricity JOHNSON & JOHNSON CONSUMER INC. 2005-01-06 US disclosed
US-20050004508-A1 Methods of reducing the appearance of pigmentation with galvanic generated electricity KENVUE BRANDS LLC 2005-01-06 US disclosed
US-20050004509-A1 Methods of administering an active agent to a human barrier membrane with galvanic generated electricity KENVUE BRANDS LLC 2005-01-06 US disclosed
CN-1170604-C Electrotransport device including a compatible antimicrobial agent 2004-10-13 CN disclosed
CN-1324259-A Electrotransport device including a compatible antimicrobial agent ALZA CORP (US) 2001-11-28 CN disclosed
EP-1135188-A1 ELECTROTRANSPORT DEVICE INCLUDING A COMPATIBLE ANTIMICROBIAL AGENT ALZA CORPORATION (US) 2001-09-26 EP disclosed
US-6181963-B1 Transdermal electrotransport delivery device including a cathodic reservoir containing a compatible antimicrobial agent ALZA CORPORATION 2001-01-30 US disclosed
WO-2000025858-A1 ELECTROTRANSPORT DEVICE INCLUDING A COMPATIBLE ANTIMICROBIAL AGENT ALZA CORPORATION (US) 2000-05-11 WO disclosed